These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 29379211)
21. Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo. Chen J; Yan B; Chen Q; Yao Y; Wang H; Liu Q; Zhang S; Wang H; Chen Z Arch Virol; 2014 Mar; 159(3):471-83. PubMed ID: 24057757 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody therapy and viral infections: update and beyond. Antonelli G Clin Microbiol Infect; 2011 Dec; 17(12):1757-8. PubMed ID: 22010631 [No Abstract] [Full Text] [Related]
28. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice. Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088 [TBL] [Abstract][Full Text] [Related]
29. Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design. Burton DR; Hangartner L Annu Rev Immunol; 2016 May; 34():635-59. PubMed ID: 27168247 [TBL] [Abstract][Full Text] [Related]
30. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts. Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262 [TBL] [Abstract][Full Text] [Related]
31. Feverish Quest for Ebola Immunotherapy: Straight or Cocktail? Saphire EO; Aman MJ Trends Microbiol; 2016 Sep; 24(9):684-686. PubMed ID: 27338027 [TBL] [Abstract][Full Text] [Related]
32. Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report. Vlaspolder F; Kraaijeveld CA; van Buuren R; Harmsen M; Benaissa-Trouw BJ; Snippe H Arch Virol; 1988; 98(1-2):123-30. PubMed ID: 2829795 [TBL] [Abstract][Full Text] [Related]
35. Bispecific antibodies for viral immunotherapy. Nyakatura EK; Soare AY; Lai JR Hum Vaccin Immunother; 2017 Apr; 13(4):836-842. PubMed ID: 27786606 [TBL] [Abstract][Full Text] [Related]
36. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza. Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342 [TBL] [Abstract][Full Text] [Related]
37. Recombinant human polyclonal antibodies: A new class of therapeutic antibodies against viral infections. Bregenholt S; Jensen A; Lantto J; Hyldig S; Haurum JS Curr Pharm Des; 2006; 12(16):2007-15. PubMed ID: 16787244 [TBL] [Abstract][Full Text] [Related]
38. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection. Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930 [TBL] [Abstract][Full Text] [Related]
39. Back to the future: antibody-based strategies for the treatment of infectious diseases. Oral HB; Ozakin C; Akdiş CA Mol Biotechnol; 2002 Jul; 21(3):225-39. PubMed ID: 12102547 [TBL] [Abstract][Full Text] [Related]
40. Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus. Wang Q; Yang H; Liu X; Dai L; Ma T; Qi J; Wong G; Peng R; Liu S; Li J; Li S; Song J; Liu J; He J; Yuan H; Xiong Y; Liao Y; Li J; Yang J; Tong Z; Griffin BD; Bi Y; Liang M; Xu X; Qin C; Cheng G; Zhang X; Wang P; Qiu X; Kobinger G; Shi Y; Yan J; Gao GF Sci Transl Med; 2016 Dec; 8(369):369ra179. PubMed ID: 27974667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]